Breast milk study of malaria medicine after childbirth
Part of Infections clinical trials.
This study measures how a medicine called an 8-aminoquinoline passes into breast milk after birth, to help prevent malaria in new mothers. If you and your baby have normal G6PD levels and you plan to exclusively breastfeed, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Both you and your baby need to have a normal G6PD enzyme level (more than 70% of normal) on a special blood test.
- You must have given birth to a healthy single baby within the last 48 hours.
- You must have a history of vivax malaria (confirmed in your health records).
- You must plan to exclusively breastfeed for at least two months after delivery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of tafenoquine (an antimalarial medicine) in children from Papua New Guinea who have uncomplicated malaria. It aims to see how the drug works in children who have normal G6PD activity.
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
This trial tests how well the drug primaquine works for people with vivax malaria who have intermediate or low levels of an enzyme called G6PD. It aims to find safe and effective treatment options for this group.
This trial tests whether adding the drug tafenoquine to standard malaria treatment can prevent the return of P. vivax malaria. It is for adults who have a normal G6PD enzyme level and are healthy enough to participate.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
This trial tests whether a shorter course of primaquine can effectively prevent relapses of vivax malaria. It aims to make treatment easier and safer for patients.
Hear when a new Drug Pharmacokinetics in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.